Skymax Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 19-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 19-12-2024
- Company Age 31 Year, 1 Month
- Last Filing with ROC 31 Mar 2011
- Open Charges ₹ 8.06 M
as on 19-12-2024
- Satisfied Charges ₹ 5.55 Cr
as on 19-12-2024
About Skymax Laboratories
The Corporate was formerly known as Skymax Laboratories P Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2011. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹8.06 M. The company has closed loans amounting to ₹5.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anilkumar Patel, Rasiklal Kadivar, and Rajiv Parmar serve as directors at the Company.
- CIN/LLPIN
U24230GJ1993PLC020662
- Company No.
020662
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Nov 1993
- Date of AGM
30 Sep 2011
- Date of Balance Sheet
31 Mar 2011
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Skymax Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anilkumar Patel  | Director | 11-Nov-1993 | Current |
| Rasiklal Kadivar | Director | 06-Jun-2005 | Current |
| Rajiv Parmar | Additional Director | 28-Jun-2018 | Current |
Financial Performance of Skymax Laboratories.
Enhance accessibility to Skymax Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Skymax Laboratories?
Unlock access to Skymax Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Skymax Cropscience LimitedActive 13 years 8 monthsAnilkumar Patel and Rasiklal Kadivar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dena Bank Creation Date: 27 Nov 2008 | ₹8.00 M | Open |
State Bank Of Saurashtra Creation Date: 13 Oct 1995 | ₹0.06 M | Open |
Hdfc Bank Limited Creation Date: 05 Apr 2006 | ₹2.75 Cr | Satisfied |
How Many Employees Work at Skymax Laboratories?
Unlock and access historical data on people associated with Skymax Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skymax Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skymax Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
